Dutasteride Capsule, Liquid Filled
Product Images NDC 50090-7305

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dutasteride (NDC 50090-7305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Dutesteride Fig1)

This text provides information about the mean change in the American Urological Association Symptom Index (AUA-SI) from baseline for a study involving Placebo and Dutasteride treatment over several months. The sample sizes for each group are 212.*

FDA Label Image

Figure (Dutesteride Fig2)

"Permentof Patients" study involves two groups - Placebo Group and Dutasteride Group. The placebo group has had 19 events and the Dutasteride group had 22 events cumulatively. The study has been tracking these events over several months of treatment in the year 2009."*

FDA Label Image

Figure (Dutesteride Fig3)

FDA Label Image

Figure (Dutesteride Fig4)

FDA Label Image

Figure (Dutesteride Fig5)

FDA Label Image

Figure (Dutesteride Fig6)

This text appears to show a comparison of the mean change from baseline in PSS (Prostate Symptom Score) after treatment with Dutasteride + Tamsulosin, consisting of Dutasteride 0.5 mg and Tamsulosin 0.4 mg. The data includes the number of participants (n) and the percentage change observed over a period of 6 months.*

FDA Label Image

Figure (Dutesteride Fig7)

"Months of Treatment" data displayed for three different sets are shown in the text. The sets indicate the number of patients enrolled and the specific medication/treatment administered to them. The treatments listed include A Dusstride + amsulosin, O Dusteride 0.5 mg, and Tamsulosin 0.4mg. Each treatment set is associated with the number of patients (n) who received the treatment."*

FDA Label Image

Chemical Structure (Dutesteride Str)

FDA Label Image

Label Image (Lbl500907305)

This is a description of a product called "Biotasteride" in capsule form, with a quantity of 30 capsules. The product number is "6632-0" and it contains 0.5 mg. The text also mentions "Stone AT 6107 pecaces" and "FRTEEY o woRTORE" which are not clear and may not be relevant to the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.